Skip to main content
Log in

Recurrent pregnancy losses and the role of immunotherapy

  • Review Article
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract 

Post implantation pregnancy losses are psychologically and economically stressful to the childbearing population. The etiology in the vast majority of cases is unknown but is partly thought to result from a breakdown of the maternal tolerance to the fetoplacental unit. Immunologically based therapy remains controversial but no alternative therapy is available at the moment. This article reviews the conceived immunological basis of recurrent pregnancy losses, discussing the controversies arising, and recommending the use of intravenous immunoglobulin, IVIg, in well controlled experiments for further clinical trials.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: August 1999 / Accepted: 10 December 1999

Rights and permissions

Reprints and permissions

About this article

Cite this article

Omwandho, C., Tinneberg, H., Tumbo-Oeri, A. et al. Recurrent pregnancy losses and the role of immunotherapy. Arch Gynecol Obstet 264, 3–12 (2000). https://doi.org/10.1007/PL00007480

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/PL00007480

Navigation